Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Invivo Therapeutics Holdings Corp (NVIV)

Invivo Therapeutics Holdings Corp (NVIV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,917
  • Shares Outstanding, K 550
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,420 K
  • 60-Month Beta 1.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.15 +38.31%
on 02/04/20
10.95 -34.98%
on 01/22/20
-1.04 (-12.75%)
since 01/14/20
3-Month
3.69 +92.80%
on 11/25/19
13.57 -47.52%
on 11/15/19
-6.34 (-47.12%)
since 11/14/19
52-Week
3.69 +92.80%
on 11/25/19
52.14 -86.34%
on 03/08/19
-36.08 (-83.52%)
since 02/14/19

Most Recent Stories

More News
InVivo Therapeutics Announces Reverse Stock Split

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced a 1-for-30 reverse stock split of its common stock and a proportionate reduction in its authorized common stock. The company anticipates...

NVIV : 7.12 (-0.56%)
After Yesterday's Decline of 7.07%, Invivo Therapeut Offers Investors Better Value

Invivo Therapeut (NASDAQ:NVIV) traded in a range yesterday that spanned from a low of $0.26 to a high of $0.29. Yesterday, the shares fell 7.1%, which took the trading range below the 3-day low of $0.27...

NVIV : 7.12 (-0.56%)
Invivo Therapeut Rises 7.16% on Heavy Volume: Watch For Potential Pullback

Invivo Therapeut (NASDAQ:NVIV) traded in a range yesterday that spanned from a low of $0.16 to a high of $0.19. Yesterday, the shares gained 7.2%, which took the trading range above the 3-day high of...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Closing of Public Offering of Common Stock

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) today announced the closing of its previously announced public offering of 7,000,000 shares of its common stock, par value $0.00001 per share, at a price...

NVIV : 7.12 (-0.56%)
Watch for Invivo Therapeut to Potentially Rebound After Falling 34.51% Yesterday

Invivo Therapeut (NASDAQ:NVIV) traded in a range yesterday that spanned from a low of $0.13 to a high of $0.17. Yesterday, the shares fell 34.5%, which took the trading range below the 3-day low of $0.22...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Pricing of Public Offering of Common Stock

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) today announced the pricing of a public offering of 7,000,000 shares of its common stock, par value $0.00001 per share, at a price to the public of $0.12...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Proposed Public Offering of Common Stock

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) today announced that it has commenced a proposed public offering of shares of its common stock, par value $0.00001 per share. The proposed public offering...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Appointment of Robert Rosenthal to Board of Directors

InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Robert J. Rosenthal, Ph.D., to the Company's Board of Directors, effective November 8, 2019. Dr. Rosenthal brings more than...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Provides Enrollment Update for INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury

InVivo Therapeutics Holdings Corp. (NVIV) today announced that a total of five patients have been enrolled into The INSPIRE 2.0 Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold(TM)...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the publication of a manuscript in the peer-reviewed journal Spinal Cord describing its CONTEMPO registry study data. The CONTEMPO registry...

NVIV : 7.12 (-0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade NVIV with:

Business Summary

InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible...

See More

Key Turning Points

2nd Resistance Point 8.29
1st Resistance Point 7.70
Last Price 7.12
1st Support Level 6.63
2nd Support Level 6.15

See More

52-Week High 52.14
Fibonacci 61.8% 33.63
Fibonacci 50% 27.92
Fibonacci 38.2% 22.20
Last Price 7.12
52-Week Low 3.69

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar